4
Changes in Ownership
Evofem Biosciences, Inc. Filed Acc 0001209191-15-086398
Chief Financial Officer sold 1,005 shares at $1.26 ($1,266)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Knudson Susan A. Chief Financial Officer | 2015-12-17 | Sale | −1,005 | $1.26 | $1,266 | 0 | D: show line 1 in the form |
| Open-market sales · 1,005 sh · avg $1.26 · $1,266 | |||||||
Loading xslF345X03/doc4.xml…